Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Trial Number
NCT00803062 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Recurrent Cervical